Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Edward Schwarz
University of Rochester, Department: Orthopedics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Telephus
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Schwarz is a founder and Chief Scientific Advisor, and currently controls an equity interest in Telephus Biosciences, LLC. Telephus is a start-up company that develops treatments for orthopaedic infections in total joint replacement procedures. Telephus has licensed IP that is owned by the University of Rochester, specifically a monoclonal antibody to prevent MRSA infection in total hip and knee replacement. The monoclonal antibody was created in Dr. Schwarz’s lab; Dr. Schwarz is named as a co-inventor. Because of the overlapping aims, it has been determined that Dr. Schwarz’s financial interest in Telephus could directly and significantly affect the design, conduct and reporting of the NIH grant.
Center of Research Translation on the Osteoimmunology of Bone Infection
Narrative Prosthetic joint infection (PJI) is the bane of elective total joint replacement (TJR) surgery, of which the vast majority is caused by Staphylococcal species. These infections are life threatening, incurable, and very expensive to treat. To address this we propose the Center of Research Translation on the Osteoimmunology of Bone Infection (CoRTOBI), which will increase our knowledge on the microbial pathogenesis of bone infection and the host response, and develop novel diagnostics and interventions for patients with bone infections.
Filed on June 19, 2018.
Tell us what you know about Edward Schwarz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.